How should I diagnose and manage a patient with hypotension (BP 103/60 mmHg), sinus bradycardia (heart rate 47‑53 bpm) and a prolonged QT interval on a 12‑lead ECG?

Management of Prolonged QT Interval with Sinus Bradycardia and Hypotension

In a patient presenting with hypotension (BP 103/60 mmHg), sinus bradycardia (HR 47-53 bpm), and prolonged QT interval, immediately identify and eliminate reversible causes—particularly QT-prolonging medications, electrolyte abnormalities (hypokalemia, hypomagnesemia, hypocalcemia), and hypothyroidism—while avoiding beta-blockers until you determine whether this is acquired versus congenital long QT syndrome. 1

Immediate Diagnostic Approach

Measure the QT Interval Correctly

• Manually verify the QTc using lead II or V5 (automated measurements are unreliable)
• Measure from QRS onset to where the T wave downslope intersects the baseline
• Apply Bazett's formula for correction
• Critical thresholds: QTc ≥500 ms indicates high risk for torsades de pointes (TdP); QTc ≥480 ms is definitely abnormal 1

Distinguish Acquired vs Congenital LQTS

Acquired LQTS (aLQTS) is far more likely in this presentation given the combination of bradycardia and hypotension. The key differentiating features:

Check immediately for:

• Medications: Review ALL current medications using www.crediblemeds.org—focus on the "anti's": antibiotics (macrolides, fluoroquinolones), antifungals, antiarrhythmics, antipsychotics/antidepressants (especially citalopram, escitalopram), antiemetics, analgesics (methadone, triptans), and chloroquine 1
• Electrolytes: Hypokalemia, hypomagnesemia, hypocalcemia are well-established causes 1
• Thyroid function: Both hypo- and hyperthyroidism can cause aLQTS 1
• Hypothermia: Check core temperature 1

Consider congenital LQTS (cLQTS) if:

• History of unexplained syncope provoked by exercise, swimming, or loud noises
• Family history of sudden unexplained death
• Seizure-like episodes (often misdiagnosed epilepsy)
• QTc remains prolonged after eliminating all reversible causes 1

Management Algorithm

Step 1: Address Life-Threatening Bradycardia First

The bradycardia itself is prolonging the QT interval and increasing TdP risk 1, 2. However, your treatment approach differs based on etiology:

For suspected aLQTS with severe bradycardia:

• Transvenous pacing or isoproterenol to increase heart rate and shorten QT interval 1
• Do NOT use beta-blockers—they worsen bradycardia and further prolong repolarization 1

For suspected cLQTS with bradycardia:

• Beta-blockade is appropriate (nadolol or propranolol) for its antiadrenergic effect to prevent premature ventricular contractions that trigger TdP 1
• This is the opposite approach from aLQTS—emphasizing why correct diagnosis is critical

Step 2: Immediate Interventions

Stop all QT-prolonging medications immediately 1

• Wait for drug washout (varies by half-life)
• Reassess ECG after washout period

Correct electrolyte abnormalities aggressively:

• Maintain potassium in high-normal range (4.5-5.0 mEq/L)
• Replete magnesium even if normal—consider supratherapeutic levels 1
• Correct hypocalcemia

Continuous cardiac monitoring for TdP detection 1

Step 3: Manage Hypotension Carefully

The hypotension (103/60 mmHg) is likely multifactorial—bradycardia reducing cardiac output plus possible medication effects.

Avoid these common pitfalls:

• Never use amiodarone or procainamide—they further prolong QT and worsen bradycardia 1
• Be cautious with vasopressors that don't increase heart rate

Preferred approach:

• If aLQTS: Isoproterenol increases heart rate AND blood pressure while shortening QT 1, 3
• If severe: Transvenous pacing provides rate support without pharmacologic effects 1

Step 4: If Torsades de Pointes Occurs

Immediate treatment sequence:

1. Intravenous magnesium sulfate (2g IV push, repeat as needed) 1, 3
2. Electrical cardioversion if prolonged or hemodynamically unstable 1, 3
3. Increase heart rate via isoproterenol or transvenous pacing to suppress recurrence 1, 3
4. Lidocaine may be used in refractory cases 1, 3

Absolutely contraindicated:

• Amiodarone (prolongs QT further)
• Procainamide (prolongs QT further)
• Class III antiarrhythmics 1

Risk Stratification

This patient has multiple high-risk features:

• QTc likely >500 ms (given symptomatic bradycardia)
• Severe bradycardia (47-53 bpm) independently prolongs repolarization 1, 2
• Hypotension suggests hemodynamic compromise
• Female sex (if applicable) increases aLQTS risk 1

Risk increases dramatically when QTc >500 ms or drug increases QTc by >60-70 ms rapidly 1

Follow-Up Diagnostic Testing

If QTc normalizes after removing reversible causes:

• No further LQTS workup needed
• Document caution with future QT-prolonging drugs 1

If QTc remains prolonged despite drug washout and electrolyte correction:

• Refer to inherited arrhythmia clinic (www.heartsinrhythm.ca or www.sads.org) 1
• Consider exercise testing—abnormal QTc prolongation at 4 minutes post-exercise suggests concealed cLQTS 1
• Genetic testing may be indicated by specialists 1

Common Pitfalls to Avoid

1. Relying on automated QTc measurements—manually verify every time 1
2. Using beta-blockers for aLQTS with bradycardia—this worsens the situation 1
3. Treating bradycardia with permanent pacing before identifying reversible causes 4
4. Missing intraclass differences in drug risk—erythromycin is much worse than azithromycin; citalopram worse than sertraline 1
5. Forgetting that bradycardia itself prolongs QT—creating a vicious cycle 1, 2
6. Using standard antiarrhythmics (amiodarone, procainamide) for TdP—these are contraindicated 1

Specific Medication Review

Check specifically for these high-risk agents that could explain both bradycardia and QT prolongation:

• Antiarrhythmics: Sotalol, dofetilide (require baseline ECG) 1
• Antidepressants: Citalopram, escitalopram (switch to sertraline or paroxetine if needed) 1
• Antibiotics: Erythromycin, ciprofloxacin (use cephalosporins or penicillins instead) 1
• Antipsychotics: Multiple agents block cardiac ion channels 1
• Acetylcholinesterase inhibitors: Can cause bradycardia, QT prolongation, and delirium 5